Drawing for AIVELLA

USPTO serial 98945521

AIVELLA

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
ROSEN, BENJAMIN H
Law office
TMO LAW OFFICE 120

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AIVELLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Debrow

Jennifer Debrow Taft Stettinius & Hollister LLP80 South 8th Street, Suite 2200Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
035business and healthcare data predictive modeling for health insurers and health care providers in the nature of using analytic and statistic models for the understanding and predicting of patient actions for health insurers and health care providers, namely business and healthcare data analysis in the field of healthcare and health insurance; providing business marketing services by means of health care patient and insured plan member engagement and health action programs, namely, providing omnichannel communication programs for federal and state-based Medicare and Medicaid health insurance plans, and private health insurance plans and health care providers, to motivate members and patients to complete recommended health actions and assess health risks; Providing healthcare consumer engagement and behavior change programs, namely, arranging and conducting incentive reward programs for business purposes, specifically for businesses in the field of federal and state-based Medicaid and Medicare health insurance plans through the distribution of prepaid stored value cards issued by others, to promote completion of recommended health-related activities by plan membersACTIVE—
041Providing healthcare consumer engagement and behavior change education programs, namely, providing educational materials for federal and state-based Medicaid and Medicare health insurance plans and plan members for treating and managing both acute illnesses and chronic conditionsACTIVE—
042Technology services in the field of human behavior modification for purposes of health plan member and patient engagement, namely, platform as a service (PAAS), featuring computer software platforms provided to health plans and healthcare providers for entering and listing desired human behaviors, tracking, recording and monitoring compliance with desired human behaviors, and issuing rewards or incentives for modification of human behaviors in compliance with desired behaviors, excluding software for storing, relaying, tracking, measuring, or displaying biometric data, body movement, sleep, heart rate, calories burned, or activity level collected via wearable devices or sensors; Providing temporary use of online non-downloadable software applications to health plans and health care providers in the field of health care for facilitating and tracking outreach and reporting results of engagement programs, namely, software for transmitting and tracking omnichannel communication programs offered by health plans and providers to their members to encourage health action and assess health risksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 17, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Sep 17, 2026CNSLSUSPENSION LETTER WRITTEN—
Aug 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 30, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 30, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 30, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 27, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 24, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 23, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 23, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Sep 23, 2025CNSLSUSPENSION LETTER WRITTEN—
Sep 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2025DOCKASSIGNED TO EXAMINER—
Apr 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 8, 2025NWAPNEW APPLICATION ENTERED—
Jan 8, 2025MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance